Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Public ClinicalTrials.gov record NCT00241280. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study in the US intended to evaluate the safety and effectiveness of a Johnson \& Johnson Vision Care Inc, (JJVCI) contact lens for use on an extended-wear basis for up to 7 days (6 nights).
Study identification
- NCT ID
- NCT00241280
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 504 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2005
- Primary completion
- Sep 30, 2006
- Completion
- Sep 30, 2006
- Last update posted
- Mar 23, 2016
2005 – 2006
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Steven S. Grant, OD | Costa Mesa | California | 92626 | — |
| Cole, Cole, and Krohn | Fresno | California | 93704 | — |
| Fukai and Associates | Louisville | Colorado | 80027 | — |
| Peter C. Donshik, MD | Bloomfield | Connecticut | 06002 | — |
| Dr. Ted Brink and Associates | Jacksonville | Florida | 32256 | — |
| Jack J. Yager, OD | Orlando | Florida | 32803 | — |
| Clayton Eye Center | Morrow | Georgia | 30260 | — |
| Eyecare Associates | Bloomington | Illinois | 61701 | — |
| Drs. Hawks, Besler & Rogers | Gardner | Kansas | 66030 | — |
| Lee Rigel | East Lansing | Michigan | 48823 | — |
| Univ Missouri at St. Louis, College of Optometry | St Louis | Missouri | 63121 | — |
| InSight Eyecare | Warrensburg | Missouri | 64093 | — |
| Drs. Quinn, Quinn and Associates | Athens | Ohio | 45701 | — |
| Central Ohio Eyecare | Columbus | Ohio | 43202 | — |
| Kenji Hamada, OD | Grants Pass | Oregon | 97526 | — |
| West Hills Vision Center | Moon Township | Pennsylvania | 15108 | — |
| Kenneth A. Young, OD | Brentwood | Tennessee | 37027 | — |
| Gary W. Jerkins, MD | Nashville | Tennessee | 37205 | — |
| Premier Vision | Amarillo | Texas | 79119 | — |
| Charles Wegman, OD | Carrollton | Texas | 75006 | — |
| Wishnow-Sugar Vision Group | Katy | Texas | 77450 | — |
| First Eye Care Plano | Plano | Texas | 75023 | — |
| Dr. William Bogus | Salt Lake City | Utah | 84106 | — |
| Scott Jens, OD | Middleton | Wisconsin | 53562 | — |
| Snowy Range Vision Center | Laramie | Wyoming | 82070 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00241280, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2016 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00241280 live on ClinicalTrials.gov.